Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Keybanc Upgrades Toll Brothers to Sector Weight

Keybanc Upgrades Toll Brothers to Sector Weight

Keybanc analyst Kenneth Zener upgrades Toll Brothers (NYSE:TOL) from Underweight to Sector Weight.

byBenzinga Newsdesk

September 19, 2022

1 minute read

Keybanc analyst Kenneth Zener upgrades Toll Brothers (NYSE:TOL) from Underweight to Sector Weight.

Inquiry Into Baidu’s Competitor Dynamics In Interactive Media & Services Industry

By Benzinga Insights

October 26, 12:00 PM

In today’s fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct…

BIDU

If You Had Invested $100 When Joe Rogan Revealed His Bitcoin QR Address In 2014, Here’s How Much You Would Have Today

By Mehab Qureshi

July 24, 7:54 AM

Podcaster Joe Rogan has long been recognized as a steadfast advocate for Bitcoin (CRYPTO: BTC).

BTC

News

Otonomo Technologies Says In Dec. 2022 Co. Initiated Workforce Reduction Of Significant Number Of Employees As Co. Adjusts Budget For 2023

By Michael Horton

December 14, 5:52 PM

-SEC Filing

OTMO

Ascendis Pharma Announces Topline Results From TransCon hGH Achieved Statistically Superior Outcomes Compared To Placebo In Phase 3 foresiGHt Trial Of Adults With Growth Hormone Deficiency

By Benzinga Newsdesk

December 19, 9:35 AM

– On primary efficacy and key secondary endpoints, TransCon hGH demonstrated statistically significant reduction from baseline in trunk fat and increase in total body lean mass at Week 38 compared to placebo

ASND

Keybanc Upgrades Toll Brothers to Sector Weight

Related Posts

Inquiry Into Baidu’s Competitor Dynamics In Interactive Media & Services Industry

If You Had Invested $100 When Joe Rogan Revealed His Bitcoin QR Address In 2014, Here’s How Much You Would Have Today

Otonomo Technologies Says In Dec. 2022 Co. Initiated Workforce Reduction Of Significant Number Of Employees As Co. Adjusts Budget For 2023

Ascendis Pharma Announces Topline Results From TransCon hGH Achieved Statistically Superior Outcomes Compared To Placebo In Phase 3 foresiGHt Trial Of Adults With Growth Hormone Deficiency